4 Results for "

DOCK180

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DOCK180" in MCE Product Catalog:

  • Targets Recommended:
3
3 Cited Publications
Cat. No.: HY-110100
CAS No.: 310460-39-0
Purity:  99.94%
Target:  

DOCK

Research Areas:  

Inflammation/Immunology

CPYPP is a DOCK2-Rac1 interaction inhibitor. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2 DHR-2 for Rac1 in a dose-dependent manner with an IC50 of 22.8 µM. CPYPP also inhibits DOCK180 and DOCK5 and less inhibits DOCK9 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-102078
CAS No.: 303094-67-9
Purity:  99.76%
Target:  

Ras Apoptosis

Research Areas:  

Cancer

ZINC69391, a specific Rac1 inhibitor, interferes with Rac1-GEF interaction by masking Trp56 residue on Rac1 surface. ZINC69391 interferes with the interaction of Rac1 with Dock180 and reduces Rac1-GTP levels. ZINC69391 induces apoptosis, and shows antiproliferative and antimetastatic effects .
loading...
    loading...
Cat. No.: HY-102078R
CAS No.: 303094-67-9
Research Areas:  

Cancer

ZINC69391 (Standard) is the analytical standard of ZINC69391 (HY-102078). This product is intended for research and analytical applications. ZINC69391, a specific Rac1 inhibitor, interferes with Rac1-GEF interaction by masking Trp56 residue on Rac1 surface. ZINC69391 interferes with the interaction of Rac1 with Dock180 and reduces Rac1-GTP levels. ZINC69391 induces apoptosis, and shows antiproliferative and antimetastatic effects .
loading...
    loading...
Cat. No.: HY-RS03921
Research Areas:  

Others

DOCK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...